Human blood vessels release tumor necrosis factor-α from a smooth muscle cell source

Critical Care Medicine

Volumn 24, Issue 2, 1996, Pages 294-297

  Newman, Walter H ^a   Zhang, Li Ming ^a   Leeper Woodford, Sandra K ^a   Castresana, Manuel R ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

blood vessels; critical illness; cytokines; lipopolysaccharide; neutrophils; septic shock; smooth muscle cells, human; tumor necrosis factor

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOASSAY; CALCULATION; CELL CULTURE; CORONARY ARTERY BYPASS GRAFT; DATA ANALYSIS; HUMAN; HUMAN TISSUE; HYPOTHESIS; INTERNAL MAMMARY ARTERY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPTIC SHOCK; SMOOTH MUSCLE FIBER;

ANALYSIS OF VARIANCE; CELLS, CULTURED; ESCHERICHIA COLI; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MAMMARY ARTERIES; MUSCLE, SMOOTH, VASCULAR; SAPHENOUS VEIN; SHOCK, SEPTIC; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030040564     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199602000-00019     Document Type: Article

References (23)

1. Grau GE, Fajardo LF, Piguet P-F, et al: Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 1987; 237:1210-1212
2. Piguet P-F, Grau GE, Allet B, et al: Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs-host disease. J Exp Med 1987; 166:1280-1289
3. Giroir BP, Horton JW, White DJ, et al: Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock. Am J Physiol 1994; 267(Heart Circ Physiol 36):H118-H124
4. Oliff A, Defoe-Jones D, Boyer M, et al: Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 1987; 50: 555-563
5. Levine B, Kalman J, Mayer L, et al: Elevated circulating levels of tumor necrosis factor in severe heart failure. N Engl J Med 1990; 223:236-241
6. Strieter RM, Kunkel SL, Bone RC: Role of tumor necrosis factor-α in disease states and inflammation. Crit Care Med 1993; 21:8447-8463
7. Leeper-Wodford SK, Carey PD, Byrne K, et al: Tumor necrosis factor alpha and beta subtypes appear in circulation during onset of sepsis-induced lung injury. Am Rev Respir Dis 1991; 143: 1076-1082
8. Tracey KJ, Beutler B, Lowry SF, et al: Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234:470-474
9. Tracey KJ, Fong Y, Hesse DG, et al: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 1987; 330:662-664
10. Pfeffer K, Matsuyama T, Kundig TM, et al: Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock yet succumb to L. monocytogenes infection. Cell 1993; 73:457-467
11. Tracey KJ, Cerami A: Tumor necrosis factor: An updated review of its biology. Crit Care Med 1993; 21:8415-8422
12. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principal of protein dye binding. Anal Biochem 1976; 72:248-254
13. Flick DA, Gifford GE: Comparison of in vitro cell cytotoxic assay for tumor necrosis factor. J Immunol Methods 1984; 68:167-175
14. Warner SJC, Libby P: Human vascular smooth muscle cells: Target for and source of tumor necrosis factor. J Immunol 1989; 142:100-109
15. Decker T, Lohmann-Matthes ML, Karck U, et al: Comparative study of cytotoxicity, tumor necrosis factor, and prostaglandin release after stimulation of rat Kupffer cells, murine Kupffer cells, and murine inflammatory liver macrophages. J Leukocyte Biol 1989; 45: 139-146
16. Dubravec DB, Spriggs DR, Mannick JA, et al: Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor-α. Proc Natl Acad Sci USA 1990; 87:6758-6761
17. Kriegler M, Perez C, DeFay K, et al: A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF. Cell 1988; 53:45-53
18. Liu C-C, Detmers PA, Jiang S, et al: Identification and characterization of a membrane-bound cytotoxin of murine cytolytic lymphocytes that is related to tumor necrosis factor/cachectin. Proc Natl Acad Sci USA 1989; 86:3286-3290
19. Pradines-Figueres A, Raetz CRH: Processing and secretion of tumor necrosis factor-α in endotoxin-treated mono mac 6 cells are dependent on phorbol myristate acetate. J Biol Chem 1992; 267:23261-23268
20. Han J, Brown T, Beutler B: Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med 1990; 171:465-475
21. Brett J, Gerlach H, Nawroth P, et al: Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G-proteins. J Exp Med 1989; 169:1977-1991
22. Gamble JR, Harlan JM, Klebanof SJ, et al: Stimulation of adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA 1985; 82:8667-8671
23. Couffinhal T, Duplaa C, Labat L, et al: Tumor necrosis factor-α stimulates ICAM-1 expression in human vascular smooth muscle cells. Arteriosclerosis and Thrombosis 1993; 13:407-414